Skip to main content

Alzheimer’s Disease Neuroimaging Initiative

  • Conference paper
Advances in Alzheimer’s and Parkinson’s Disease

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mohs RC, Marin D, Haroutunian V. Early clinical and biological manifestations of Alzheimer's disease: implications for screening and treatment. In: Fillit HM, O'Connell AW (eds) Drug Discovery and Development for Alzheimer's Disease 2000. New York: Springer, 2002, pp 57–63

    Google Scholar 

  2. Kantarci K, Jack CR Jr. Neuroimaging in Alzheimer disease: an evidence-based review. Neuroimaging Clin N Am 2003;13(2):197–209

    Article  PubMed  Google Scholar 

  3. Kantarci K, Jack CR. Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease. NeuroRx 2004;1(2):196–205

    Article  PubMed  Google Scholar 

  4. Irizarry MC. Biomarkers of Alzheimer disease in plasma. NeuroRx 2004;1(2):226–234

    Article  PubMed  Google Scholar 

  5. Hsu Y, Schuff N, Du A, et al. Comparison of automated and manual hippocampal MR volumetry in aging and Alzheimer disease. J Magn Res Imaging 2002;16(3):305–310

    Article  Google Scholar 

  6. Davis PC, Gearing M, Gray L, et al. The CERAD experience. Part VIII. Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease. Neurology 1995;45(1):178–179

    PubMed  CAS  Google Scholar 

  7. Mielke R, Schroder R, Fink GR, et al. Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease. Acta Neuropathol (Berl) 1996;91(2):174–179

    Article  CAS  Google Scholar 

  8. De Leon MJ, DeSanti S, Zinkowski R, et al. MRI and CSF studies in the early diagnosis of Alzheimer's disease. J Intern Med 2004;256(3):205–223.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this paper

Cite this paper

Mueller, S.G. et al. (2008). Alzheimer’s Disease Neuroimaging Initiative. In: Fisher, A., Memo, M., Stocchi, F., Hanin, I. (eds) Advances in Alzheimer’s and Parkinson’s Disease. Advances in Behavioral Biology, vol 57. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-72076-0_18

Download citation

Publish with us

Policies and ethics